TMO   $493.48  -0.42% Market Open

Thermo Fisher Scientific Inc
Last Events:

2023-10-25 The hottest instrument.

2023-08-14 The hottest instrument.

2023-08-13 The hottest instrument.

2023-08-12 The hottest instrument.

2023-08-09 Trend Power changed from almost flat to slow.

2023-08-06 Trend pattern changed from расширяющаяся формация to расходящийся клин с наклоном вверх.

2023-08-06 Signal in RSI changed from bullish weakening to bullish recovery. RSI indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: exit from the overbought zone.

2023-08-05 Trend pattern changed from канал to расширяющаяся формация.

Current temperature: 21.79
ST: 0, Cor:

50-50 Year Forecast
Low with % probability:
Target: 589.20
High with % probability:
Analyst Recommendations:
Number of estimates 23
Target Price Mean 525.14
Mean unverified/preliminary 525.14 / 525.14
Target Price Low / High 435.00 / 635.00
Median / STD DEV 524.00 / 51.39
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell ActivelyBuy
rsi Sell None ActivelyBuy
macd None None None
stoch None None None
ma20 None Sell None
ma50 None None None
ma100 Sell Sell None
Candlestick PatternNov. 3, 2023 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US8835561023
ceo Mr. Marc N. Casper
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, laboratory chemicals, research and safety market channel, and pharma services and clinical research. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.